Brain Scans Reveal Damage From a Condition Unlike MS
Key Takeaway
This study found a distinct pattern of brain shrinkage in an immune-related illness, but it did not study MS or show that MS care should change.
What They Found
Researchers compared brain scans from 55 people with LGI1 autoimmune encephalitis, 55 healthy people, and 55 people with Alzheimer's disease. LGI1 autoimmune encephalitis is an illness in which the immune system mistakenly attacks a protein that helps brain cells communicate. People with this illness had more shrinkage in several brain areas involved in memory and movement than either comparison group. Some shrinkage was found even when a standard scan showed no visible damage or patients did not meet the usual criteria for this illness. Worse thinking problems at diagnosis and more time since symptoms began were linked to more shrinkage in a memory-related area.
Who Should Care and Why
People with MS and their caregivers should know that this study examined a different illness, not MS. Brain shrinkage can have different causes, much like a fever can come from different illnesses. If you have new memory or thinking problems, tell your care team rather than assuming MS is the cause. Your clinician can consider your symptoms and test results together when deciding what they mean. This study supports prompt assessment for the illness it studied, but it does not tell us whether changing MS treatment would help.
Important Considerations
The study included 55 people with LGI1 autoimmune encephalitis and no people with MS, so its results cannot be applied directly to MS. The links between symptoms, time since illness began, and brain shrinkage do not prove that earlier treatment prevents damage. Brain scans alone cannot establish what is causing a person's symptoms.
AI-generated summary — for informational purposes only, not medical advice
Categories:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read More
10/6/2026
In children with MS, immune attacks on the brain and spinal cord may go unchecked. See what research
Read More
10/6/2026
A review finds a changed protein in several brain diseases, but its role in MS is unclear. Learn wha
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.